or Try an Advanced Search...

    ETF Components for BIS - ProShares UltraShort Nasdaq Biotechnology


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    AMGN B 2.35 8.14
    GILD F 0.91 7.41
    VRTX C 0.20 7.21
    BIIB F 2.03 6.12
    ILMN F 0.63 5.67
    REGN C 0.32 4.13
    INCY F -0.89 2.09
    BMRN B -1.60 1.91
    ALNY F -0.52 1.60
    VTRS D 1.17 1.35
    SNY D 2.00 1.29
    NBIX C -0.41 1.16
    SRPT D -0.80 1.15
    NVCR F 0.33 1.10
    JAZZ F 0.61 1.03
    TECH F -0.14 1.02
    IONS D -0.32 1.02
    GH F -3.60 0.96
    AMRN F -1.43 0.85
    MRNA B -0.58 0.83
    BGNE F -1.85 0.83
    ACAD F -1.46 0.81
    ASND C -0.51 0.77
    EXEL A 0.13 0.73
    ARWR F -1.24 0.65
    BLUE F 7.03 0.65
    BBIO F -0.84 0.51
    ALLK F 0.94 0.49
    UTHR A 0.42 0.49
    NKTR B -6.06 0.48
    SAGE F 2.26 0.48
    BPMC C -2.31 0.48
    FGEN F -1.71 0.47
    DCPH D 3.09 0.43
    AGIO B 0.34 0.43
    CRSP F -1.98 0.42
    RARE D -2.33 0.42
    ADPT F 2.78 0.42
    MEDP C -0.62 0.40
    PTCT F 2.55 0.40
    ARGX F 0.51 0.40
    AXSM F 3.32 0.38
    ALLO F 0.29 0.37
    GRFS F -3.98 0.36
    IOVA D -3.50 0.36
    ALKS F 0.38 0.36
    KOD F -3.17 0.35
    HALO D 2.20 0.35
    QURE F -0.85 0.35
    FOLD D 2.71 0.32
    APLS F 0.04 0.31
    XNCR F -3.01 0.26
    MYGN D -0.05 0.26
    DNLI F -3.61 0.26
    ZLAB F -1.05 0.24
    IRWD D 4.21 0.24
    ARVN D 1.25 0.24
    INSM D -1.94 0.23
    FATE D -4.96 0.23
    PCRX F 0.57 0.22
    GLPG F 0.59 0.22
    ITCI A 0.51 0.21
    RGNX F -2.61 0.21
    ESPR D 4.28 0.19
    EDIT F -1.08 0.19
    LGND B -0.07 0.19
    INVA B 1.77 0.18
    VCYT F 1.30 0.18
    ALEC F 0.00 0.18
    TBPH B 1.52 0.17
    YMAB B 0.87 0.16
    CHRS F 3.50 0.16
    HCM A 0.86 0.15
    NGM D 0.00 0.15
    SUPN D 1.84 0.15

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Pain S&P 500 Immune System Immunology Infectious Diseases Disease Genetics Inflammation Monoclonal Antibodies Nasdaq 100 Organ Systems Cholesterol Diabetes
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies

    Recent News for ProShares UltraShort Nasdaq Biotechnology & its Holdings

    Date Stock Title
    Apr 20 TECH Peter Schiff Mocks 'Bitcoiners' After Halving Event, Asks If They're 'Throwing Parties:' 'Hodlers Will Experience A Halving Of Their Net Worths'
    Apr 19 MRNA Moderna (MRNA) Stock Moves -0.58%: What You Should Know
    Apr 19 VRTX Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
    Apr 19 GRFS Grifols 2023 Annual Report on Form 20-F filed with the SEC
    Apr 19 MRNA Moderna stock traded in the red for the eighth straight day
    Apr 19 ALNY How Is The Market Feeling About Alnylam Pharmaceuticals?
    Apr 19 ILMN 20 Countries with the Highest Cancer Survival Rates in the World
    Apr 19 ILMN Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?
    Apr 19 ITCI How Is The Market Feeling About Intra-Cellular Therapies?
    Apr 19 VRTX Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
    Apr 19 TECH Understanding Netflix, Disney Market Maneuvers: Decoding The Streaming Strategy
    Apr 19 FOLD When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
    Apr 19 REGN Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
    Apr 19 TECH Think Trading In Your iPhone Helps Keep Planet Green? Turns Out There Are Plenty Of Dirty Secrets, Report Reveals
    Apr 19 BIIB What's in Store for Biogen (BIIB) This Earnings Season?
    Apr 19 BIIB Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
    Apr 19 ILMN These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
    Apr 19 TECH 'No Real Use Case:' Cybertruck's Lead Engineer Asks What GM's 'CrabWalk' Feature Is Good For After Revealing Tesla 'Played' With Idea
    Apr 19 TECH Meta AI Chatbot Poses As Parent In NYC Facebook Group, Claims To Have Disabled Child In School: Report
    Apr 19 TECH Management Expert Warns Elon Musk Faces 'CEO Overload' After Tesla Layoffs Reportedly Leave Him Overseeing 35 Key Personnel
    The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
    Back to the Main BIS Page...